Gene or Region: LAMC2
Reference Variant: no change in LAMC2
Mutant Variant: insertion of C nucleotide
Affected Breeds: Belgian, Breton, Comtois
Research Confidence: High - Findings reproduced multiple studies
Explanation of Results: jeb1/jeb1 = homozygous for Junctional Epidermolysis Bullosa 1, trait expressed jeb1/n = heterozygous for Junctional Epidermolysis Bullosa 1, carrier n/n = no variant detected
Junctional Epidermolysis Bullosa 1 (JEB1), also known as red foot disease or hairless foal syndrome, results in the inability to produce the proteins needed to keep the skin on the body. Affected foals exhibit symptoms within days of birth, including blisters at the pressure points, detachment of the hooves, and oral ulcers. As there is no treatment, affected foals are humanely euthanized. JEB1 is an autosomal recessive condition, thus a horse must inherit two copies of the allele (jeb1/jeb1) to show any signs. Horses with only one copy of the variant (jeb1/n) are known as carriers due to their ability to produce affected foals.
LAMC2 is a subunit of a key component of basement membranes. Mutations in other subunits of this complex have been shown to result in JEB in many human populations. This particular mutation is a single base insertion that disrupts the normal amino acid sequence, resulting in an early stop codon and truncated protein.
Spirito F et al., “Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.” (2002) J Invest Dermatol. 119: 684-91. PMID: 12230513
Milenkovic D et al., “A mutation in the LAMC2 gene causes the Herlitz junctional epidermolysis bullosa (H-JEB) in two French draft horse breeds.” (2003) Genet Sel Evol. 35: 249-56. PMID: 12633536
Foal immunodeficiency syndrome (FIS) is a failure in the development of the adaptive immune system. At 3-6 weeks of age, once the maternal antibodies begin to degrade, foals exhibit signs of anemia, diarrhea, and pneumonia. As these foals fail to respond to treatment for infections, they are humanely euthanized at a young age.
Glanzmann Thrombasthenia (GT) is a blood platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings.
Glycogen Branching Enzyme Deficiency (GBED) is a lethal recessive disorder characterized by seizures, muscle weakness, respiratory failure, and death. Many affected foals do not make it full term and are aborted or stillborn. Carriers (gbed/n) have no known issues.